top of page

Fri, Dec 10


Hybrid Scientific Event

Diagnostic Imaging in Oncology and Neurology

Registration is closed
See other events
Diagnostic Imaging in Oncology and Neurology
Diagnostic Imaging in Oncology and Neurology

Time & Location

Dec 10, 2021, 3:00 PM – 8:15 PM GMT+2

Hybrid Scientific Event

About the Event

Dear Colleagues, Dear Scientists,

It is a great pleasure to invite you to our Hybrid Scientific Meeting “Diagnostic Imaging in Oncology and Neurology” on December 10th, 2021.

This Hybrid Scientific Event aims at continuing GE’s Scientific Sessions of 2021, by refreshing the Topics of Oncology, Neurology and Neuroimaging where new developments are involved.

The goal of this Scientific Event is to improve the knowledge, confidence, and performance of learners into the diagnostic evaluation of patients with Prostate and Breast cancer, of patients with Parkinson and Alzheimer Disease and on how Neuroradiology may contribute to a clear and correct diagnosis, using a voting system for the Challenging Cases presented.

We look forward to welcoming you in our Hybrid Scientific Meeting

With Best regards,

The GE Medical Team


15:00-15:10      Welcome and Opening of the Meeting

Moderators:    Dr. Koutelou Maria, Dr. Natsios Athanasios


Chair:  Dr Koutelou Maria, Dr. Prasopoulos Vasileios

15:10- 16:00    

  • Prostate   cancer, Dr. Koutsoukos Konstantinos
  • Use   of Ga-68 PSMA-11 for diagnosis, Dr. Prasopoulos Vasileios

16:00- 16:50

  • Diagnostic evaluation of metastatic breast cancer, Dr. Galani Eleni
  • Fluoroestradiol-F-18 in PET Examination, Asst. Prof. Papathanasiou Nikos

16:50- 17:00   Short Break




Chair: Asst. Prof. Kefalopoulou Zinovia, Dr. Koutsikos John

  • Parkinson Disease (PD). Unmasking an early Diagnosis, Asst. Prof. Kefalopoulou Zinovia
  • Utility of I123 Ioflupane scan, Dr. Koutsikos John

Alzheimer Disease (AD)

Chair: Asst. Prof. Kefalopoulou Zinovia, Dr. Koutsikos John

17:40- 18:40

  • Recent Trends in Alzheimer Disease, Asst. Prof. Kefalopoulou Zinovia
  • Diagnostic   impact of [18F] flutemetamol PET in early dementia diagnosis, Asst. Prof. Valotassiou Varvara
  • Theragnostics:   Aducanumab (Aduhelm) - The first approved treatment for the reduction of   beta-amyloid plaques in Alzheimer disease, Asst. Prof. Kefalopoulou Zinovia

18:40- 19:00 Break


Chair: Asst. Prof. Kefalopoulou Zinovia, Prof. Kapsalaki Eftychia

19:00- 20:00 

  • Neuroradiology in the new era, Prof. Kapsalaki Eftychia
  • Challenging Cases (Voting system), Prof. Kapsalaki Eftychia, Asst. Prof. Kefalopoulou Zinovia

20:00- 20:15

  • Q/A,   Panel Discussion
  • Final   summary of the day

Speakers, Moderators and Chairpersons:

Dr. Galani Eleni, Associate Director, 2nd Oncology Clinic, Metropolitan Hospital, Athens, Greece

Dr. Kapsalaki Eftychia, Professor of Radiology, University of Thessaly, Medical School, Larisa, Greece

Dr. Kefalopoulou Zinovia, Assistant Professor in Neurology, University of Patras, Neurology Department, Rio Hospital, Greece

Dr. Koutelou Maria, Nuclear Medicine Physician, Director Nuclear Medicine Department, Onassis Cardiac Surgery Center, Athens, Greece

Dr. Koutsikos John, Nuclear Medicine Physician, Director of Nuclear Medicine Department, “Henry Dunant” Hospital Center, Athens, Greece

Dr. Koutsoukos Konstantinos, Medical Oncologist, Eugenideio & Alexandra Hospitals, Athens, Greece

Dr. Natsios Athanasios, Medical Head South East Europe, GE Healthcare Pharmaceuticals (PDx), Athens, Greece

Dr. Papathanasiou Nikos, Assistant Professor of Nuclear Medicine, Nuclear Medicine & PET/CT Department University Hospital of Patras, Patras, Greece

Dr. Prasopoulos Vasileios, Nuclear Medicine Physician, Director Nuclear Medicine Department and PET/CT, Hygeia Hospital, Athens, Greece

Dr. Valotassiou Varvara, Assistant Professor of Nuclear Medicine, University of Thessaly, University Hospital of Larissa, Larissa, Greece

Share This Event

bottom of page